ESTRO ACROP guidelines for Target Volume Definition in the thoracic radiation treatment of Small cell lung cancer.

Le Pechoux, Cecile; Faivre-Finn, Corinne; Ramella, Sara; McDonald, Fiona; Manapov, Farkhad; Putora, Paul Martin; Slotman, Ben; De Ruysscher, Dirk; Ricardi, Umberto; Geets, Xavier; Belderbos, José; Pöttgen, Christoph; Dziadiuszko, Rafal; Peeters, Stephanie; Lievens, Yolande; Hurkmans, Coen; Van Houtte, Paul; Nestle, Ursula (2020). ESTRO ACROP guidelines for Target Volume Definition in the thoracic radiation treatment of Small cell lung cancer. Radiotherapy and oncology, 152, pp. 89-95. Elsevier 10.1016/j.radonc.2020.07.012

[img]
Preview
Text
1-s2.0-S0167814020304059-main.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (535kB) | Preview

Radiotherapy (RT) plays a major role in the treatment of small cell lung cancer (SCLC). Therefore, the ACROP committee was asked by ESTRO to provide recommendations on target volume delineation for standard clinical scenarios in definitive (chemo)-radiotherapy (CRT), adjuvant RT for stages I-III SCLC and consolidation thoracic RT for stage IV disease. The aim of these guidelines is to standardise and optimise the process of RT treatment planning for clinical practice and prospective studies. The process for the development of the guidelines included the evaluation of a structured questionnaire followed by a consensus discussion, voting and writing process within the committee. Firstly, we provide recommendations for both the imaging to be performed as part of the diagnostic work-up and for the RT planning process. Secondly, recommendations are made for target volume delineation including delineation of the primary gross tumour volume (GTV) and lymph node GTV and clinical tumour volume (CTV) expansion in the context of definitive and adjuvant RT. With regard to internal target volume (ITV) and planning target volume (PTV) definitions, we make recommendations about the management of geometric uncertainties and target motion. Finally, we provide our opinions on organ at risk (OAR) delineation and organisational issues to be considered.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Putora, Paul Martin

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0167-8140

Publisher:

Elsevier

Language:

English

Submitter:

Beatrice Scheidegger

Date Deposited:

20 Jul 2020 11:18

Last Modified:

14 Jul 2021 02:30

Publisher DOI:

10.1016/j.radonc.2020.07.012

PubMed ID:

32673777

Uncontrolled Keywords:

Conformal Radiotherapy Small Cell Lung Cancer Target volumes combined modality treatment

BORIS DOI:

10.7892/boris.145258

URI:

https://boris.unibe.ch/id/eprint/145258

Actions (login required)

Edit item Edit item
Provide Feedback